Cargando…

Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment

Cancer is associated with single or multiple gene defects. Recently, much research has focused on incorporating genetic materials as one of the means to treat various types of carcinomas. RNA interference (RNAi) conveys an alternative genetic approach for cancer patients, especially when conventiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hattab, Dima, Gazzali, Amirah Mohd, Bakhtiar, Athirah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309123/ https://www.ncbi.nlm.nih.gov/pubmed/34371702 http://dx.doi.org/10.3390/pharmaceutics13071009

Ejemplares similares

Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements
por: Hattab, Dima, et al.
Publicado: (2020)

Peptide-siRNA nanotherapeutics in arthritis
por: Pham, Christine T.N., et al.
Publicado: (2015)

The emerging potential of siRNA nanotherapeutics in treatment of arthritis
por: Kumari, Anjali, et al.
Publicado: (2023)

Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer
por: Kamaruzman, Nur Izyani, et al.
Publicado: (2019)

siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review
por: Sargazi, Saman, et al.
Publicado: (2022)

Antituberculosis Targeted Drug Delivery as a Potential Future Treatment Approach
por: Mazlan, Mohd Khairul Nizam, et al.
Publicado: (2021)

Nanotherapeutics Using an HIV-1 Poly A and Transactivator of the HIV-1 LTR-(TAR-) Specific siRNA
por: Mahajan, Supriya D., et al.
Publicado: (2011)

Strontium Sulfite: A New pH-Responsive Inorganic Nanocarrier to Deliver Therapeutic siRNAs to Cancer Cells
por: Karim, Md. Emranul, et al.
Publicado: (2019)

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
por: Foster, Donald J., et al.
Publicado: (2018)

Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Design of advanced siRNA therapeutics for the treatment of COVID-19
por: Niktab, Iman, et al.
Publicado: (2021)

Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013)

Advances in personalized nanotherapeutics
por: Kaushik, Ajeet, et al.
Publicado: (2017)

Advances in siRNA therapeutics and synergistic effect on siRNA activity using emerging dual ribose modifications
por: Gangopadhyay, Sumit, et al.
Publicado: (2022)

Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment
por: Xie, Xiaowei, et al.
Publicado: (2023)

Cyclic Peptides for the Treatment of Cancers: A Review
por: Ramadhani, Dalifa, et al.
Publicado: (2022)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

sIR: siRNA Information Resource, a web-based tool for siRNA sequence design and analysis and an open access siRNA database
por: Shah, Jyoti K, et al.
Publicado: (2007)

Knocking down barriers: advances in siRNA delivery
por: Whitehead, Kathryn A., et al.
Publicado: (2009)

Recent advances in nanotherapeutics for the treatment of burn wounds
por: Huang, Rong, et al.
Publicado: (2021)

Insights on prospects of nano-siRNA based approaches in treatment of Cancer
por: Goyal, Rajat, et al.
Publicado: (2022)

Predicting siRNA efficacy based on multiple selective siRNA representations and their combination at score level
por: He, Fei, et al.
Publicado: (2017)

Recent advances in siRNA delivery mediated by lipid-based nanoparticles
por: Yonezawa, Sei, et al.
Publicado: (2020)

siRNA Targeting and Treatment of Gastrointestinal Diseases
por: Chevalier, Rachel
Publicado: (2019)

Advances in Targeting Cancer-Associated Genes by Designed siRNA in Prostate Cancer
por: Bahreyni, Amirhossein, et al.
Publicado: (2020)

Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease
por: Woitok, Marius Maximilian, et al.
Publicado: (2020)

Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview
por: A. Razak, S. Aishah, et al.
Publicado: (2021)

Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)

Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)

siRNA for Influenza Therapy
por: Barik, Sailen
Publicado: (2010)

Retrovirus-delivered siRNA
por: Devroe, Eric, et al.
Publicado: (2002)

Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)

Advances in Nanomaterials Used in Co-Delivery of siRNA and Small Molecule Drugs for Cancer Treatment
por: Chung, Shei Li, et al.
Publicado: (2021)

Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activities
por: Ichihara, Masatoshi, et al.
Publicado: (2007)

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013)

Expression data of HeLa cells treated with CENP-E siRNA or Eg5 siRNA in the presence of BubR1 siRNA
por: Nakayama, Yusuke, et al.
Publicado: (2015)

Photochemical Internalization of siRNA for Cancer Therapy
por: Ali, Lamiaa Mohamed Ahmed, et al.
Publicado: (2022)

Nanotherapeutic Intervention in Photodynamic Therapy for Cancer
por: Itoo, Asif Mohd, et al.
Publicado: (2022)

siRNA potency enhancement via chemical modifications of nucleotide bases at the 5′-end of the siRNA guide strand
por: Shinohara, Fumikazu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rqi7g9m15m3hujvnlmmcvr0j5m